Dublin, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The "Cone Rod Dystrophy Market - A Global and Regional Analysis: Focus on Regional and Country Analysis - Analysis and Forecast, 2025-2035" report has been ...
(RTTNews) - Ocugen, Inc. (OCGN) announced the FDA has granted Rare Pediatric Disease Designation for OCU410ST for the treatment of ABCA4-associated retinopathies including Stargardt disease, retinitis ...
Ocugen Inc.’s OCU-410ST (AAV5-hRORA) has been awarded orphan drug designation by the FDA for the treatment of ABCA4-associated retinopathies, including Stargardt disease, retinitis pigmentosa 19 (RP19 ...
(MENAFN- GlobeNewsWire - Nasdaq) Cone rod dystrophy is a rare inherited retinal disorder impacting cones and rods, leading to progressive vision loss. The market for cone rod dystrophy is poised for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback